rxstat › Classes › Drugs Affecting Bone Structure And Mineralization

Drugs Affecting Bone Structure And Mineralization: shortage status in Canada

6 of the 7 drugs affecting bone structure and mineralization rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Partial shortageAlendronic Acid3 of 20 reported products affected · est. return Jun 30, 2026 Partial shortageAlendronic Acid Vitamin D32 of 8 reported products affected Partial shortageEtidronate Disodium1 of 2 reported products affected Partial shortagePamidronate Disodium1 of 7 reported products affected Partial shortageRisedronate3 of 23 reported products affected · est. return Dec 30, 2022 Partial shortageZoledronic Acid2 of 14 reported products affected · est. return Jul 6, 2026 DiscontinuedClodronate Disodium0 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.